Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	qox	pox_cutoff	pox	oxoGCut	isArtifactMode	t_ref_count	t_alt_count
ARHGAP4	393	broad.mit.edu	37	X	153186831	153186831	+	Missense_Mutation	SNP	C	G	G			TCGA-FE-A23A-01A-11D-A17V-08	TCGA-FE-A23A-10A-01D-A17V-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	60711e67-e8c1-470a-8e9e-1b87e0499e61	7ead3f16-6be4-4546-872e-6af784e1258c	g.chrX:153186831C>G	uc004fjk.2	-	2	480	c.422G>C	c.(421-423)cGc>cCc	p.R141P	ARHGAP4_uc011mzf.2_Missense_Mutation_p.R118P|ARHGAP4_uc004fjl.2_Missense_Mutation_p.R141P|ARHGAP4_uc010nup.2_Non-coding_Transcript	NM_001666	NP_001657	P98171	RHG04_HUMAN	Homo sapiens Rho GTPase activating protein 4 (ARHGAP4), transcript variant 2, mRNA.	141					Rho protein signal transduction|apoptosis|cytoskeleton organization|induction of apoptosis by extracellular signals|nerve growth factor receptor signaling pathway	cytosol|focal adhesion|nucleus	Rho GTPase activator activity|Rho guanyl-nucleotide exchange factor activity|SH3/SH2 adaptor activity			central_nervous_system(2)|endometrium(2)|large_intestine(1)|lung(7)|skin(1)|upper_aerodigestive_tract(1)	14	all_cancers(53;6.72e-15)|all_epithelial(53;3.19e-09)|all_lung(58;3.39e-06)|all_hematologic(71;4.25e-06)|Lung NSC(58;4.7e-06)|Acute lymphoblastic leukemia(192;6.56e-05)					CTTGACCAGGCGCCCCACGTC	0.682													0	1.98E-03	0	0	0	37	6
MUC16	94025	broad.mit.edu	37	19	9090831	9090831	+	Silent	SNP	A	G	G			TCGA-FE-A23A-01A-11D-A17V-08	TCGA-FE-A23A-10A-01D-A17V-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	60711e67-e8c1-470a-8e9e-1b87e0499e61	7ead3f16-6be4-4546-872e-6af784e1258c	g.chr19:9090831A>G	uc002mkp.3	-	0	1188	c.984T>C	c.(982-984)ccT>ccC	p.P328P		NM_024690	NP_078966	Q8WXI7	MUC16_HUMAN	Homo sapiens mucin 16, cell surface associated (MUC16), mRNA.	328	Thr-rich.				cell adhesion	extracellular space|extrinsic to membrane|integral to membrane|plasma membrane	protein binding			NS(9)|autonomic_ganglia(1)|breast(26)|central_nervous_system(11)|cervix(1)|endometrium(46)|haematopoietic_and_lymphoid_tissue(5)|kidney(35)|large_intestine(91)|liver(1)|lung(278)|ovary(17)|pancreas(2)|prostate(17)|skin(18)|soft_tissue(1)|stomach(8)|upper_aerodigestive_tract(16)|urinary_tract(7)	590						TCATGGAAAAAGGGATAGCTG	0.522													0	4.67E-03	0	0	0	69	3
CD109	135228	broad.mit.edu	37	6	74528131	74528131	+	Missense_Mutation	SNP	G	A	A			TCGA-FE-A23A-01A-11D-A17V-08	TCGA-FE-A23A-10A-01D-A17V-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	60711e67-e8c1-470a-8e9e-1b87e0499e61	7ead3f16-6be4-4546-872e-6af784e1258c	g.chr6:74528131G>A	uc003php.3	+	30	4363	c.3932G>A	c.(3931-3933)aGt>aAt	p.S1311N	CD109_uc003phq.3_Missense_Mutation_p.S1294N|CD109_uc010kba.3_Missense_Mutation_p.S1234N	NM_133493	NP_598000	Q6YHK3	CD109_HUMAN	Homo sapiens CD109 molecule (CD109), transcript variant 1, mRNA.	1311						anchored to membrane|extracellular space|plasma membrane	serine-type endopeptidase inhibitor activity			NS(2)|biliary_tract(1)|breast(1)|endometrium(4)|kidney(2)|large_intestine(18)|liver(2)|lung(26)|ovary(2)|pancreas(1)|prostate(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	63						CCGGGTAGGAGTGGCATGGCT	0.408													0	1.98E-03	0	0	0	26	5
HNRNPH2	3188	broad.mit.edu	37	X	100668067	100668067	+	Missense_Mutation	SNP	C	T	T			TCGA-FE-A23A-01A-11D-A17V-08	TCGA-FE-A23A-10A-01D-A17V-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	60711e67-e8c1-470a-8e9e-1b87e0499e61	7ead3f16-6be4-4546-872e-6af784e1258c	g.chrX:100668067C>T	uc022cai.1	+	0	1091	c.1091C>T	c.(1090-1092)aCt>aTt	p.T364I	RPL36A-HNRNPH2_uc022cag.1_3'UTR|RPL36A-HNRNPH2_uc022cah.1_3'UTR|HNRNPH2_uc004ehm.3_Missense_Mutation_p.T364I|HNRNPH2_uc004ehn.3_Missense_Mutation_p.T364I	NM_019597	NP_062543	P55795	HNRH2_HUMAN	Homo sapiens heterogeneous nuclear ribonucleoprotein H2 (H') (HNRNPH2), transcript variant 1, mRNA.	364	2 X 16 AA Gly-rich approximate repeats.|2 X 19 AA perfect repeats.|RRM 3.				nuclear mRNA splicing, via spliceosome	actin cytoskeleton|cytoplasm|heterogeneous nuclear ribonucleoprotein complex|nucleoplasm	RNA binding|nucleotide binding|protein binding			breast(3)|large_intestine(2)|lung(6)|skin(1)	12						TTAAATTCTACTGCAGGAACA	0.433													0	4.88E-03	0	0	0	93	39
PAPOLG	64895	broad.mit.edu	37	2	60988874	60988874	+	Splice_Site	SNP	A	G	G			TCGA-FE-A23A-01A-11D-A17V-08	TCGA-FE-A23A-10A-01D-A17V-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	60711e67-e8c1-470a-8e9e-1b87e0499e61	7ead3f16-6be4-4546-872e-6af784e1258c	g.chr2:60988874A>G	uc002sai.3	+	3	429	c.180_splice	c.e3-2	p.R60_splice	PAPOLG_uc002saj.3_Splice_Site|PAPOLG_uc002sak.3_Splice_Site	NM_022894	NP_075045	Q9BWT3	PAPOG_HUMAN	Homo sapiens poly(A) polymerase gamma (PAPOLG), mRNA.	60					RNA polyadenylation|mRNA processing|transcription, DNA-dependent	nucleus	ATP binding|RNA binding|metal ion binding|polynucleotide adenylyltransferase activity			breast(2)|central_nervous_system(1)|endometrium(5)|kidney(3)|large_intestine(6)|liver(1)|lung(11)|ovary(1)|prostate(1)|skin(3)|upper_aerodigestive_tract(1)	35	all_hematologic(2;0.0797)		LUSC - Lung squamous cell carcinoma(5;1.19e-07)|Lung(5;2.86e-06)|Epithelial(17;0.0768)			TTTTTTTTATAGGCTGGTGGT	0.328													0	4.67E-03	0	0	0	40	3
CIAPIN1	57019	broad.mit.edu	37	16	57474766	57474766	+	Silent	SNP	C	T	T			TCGA-FE-A23A-01A-11D-A17V-08	TCGA-FE-A23A-10A-01D-A17V-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	60711e67-e8c1-470a-8e9e-1b87e0499e61	7ead3f16-6be4-4546-872e-6af784e1258c	g.chr16:57474766C>T	uc002ell.1	-	1	246	c.75G>A	c.(73-75)ctG>ctA	p.L25L	CIAPIN1_uc002elm.1_Silent_p.L25L|CIAPIN1_uc010vhm.1_Silent_p.L25L	NM_020313	NP_064709	Q6FI81	CPIN1_HUMAN	Homo sapiens cytokine induced apoptosis inhibitor 1 (CIAPIN1), mRNA.	25					anti-apoptosis|apoptosis	cytoplasm|nucleolus				cervix(1)|endometrium(1)|kidney(1)|large_intestine(2)|lung(4)|urinary_tract(1)	10						CCAGACCTTTCAGAGCCTCCA	0.522													0	4.48E-03	0	0	0	57	9
SLC6A2	6530	broad.mit.edu	37	16	55732393	55732393	+	Missense_Mutation	SNP	G	A	A			TCGA-FE-A23A-01A-11D-A17V-08	TCGA-FE-A23A-10A-01D-A17V-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	60711e67-e8c1-470a-8e9e-1b87e0499e61	7ead3f16-6be4-4546-872e-6af784e1258c	g.chr16:55732393G>A	uc021tio.1	+	9	1453	c.1402G>A	c.(1402-1404)Gtc>Atc	p.V468I	SLC6A2_uc002eif.3_Missense_Mutation_p.V468I|SLC6A2_uc002eig.3_Missense_Mutation_p.V468I|SLC6A2_uc002eii.3_Missense_Mutation_p.V363I|SLC6A2_uc002eij.3_Missense_Mutation_p.V182I|SLC6A2_uc021tip.1_5'Flank	NM_001172504	NP_001165975	P23975	SC6A2_HUMAN	Homo sapiens solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 (SLC6A2), transcript variant 1, mRNA.	468					synaptic transmission	integral to plasma membrane|membrane fraction	norepinephrine:sodium symporter activity			breast(1)|endometrium(3)|kidney(1)|large_intestine(8)|lung(20)|ovary(3)|pancreas(2)|prostate(2)|upper_aerodigestive_tract(1)	41				BRCA - Breast invasive adenocarcinoma(181;0.01)|Kidney(780;0.0267)	Amineptine(DB04836)|Amitriptyline(DB00321)|Amoxapine(DB00543)|Atomoxetine(DB00289)|Bethanidine(DB00217)|Bupropion(DB01156)|Clomipramine(DB01242)|Cocaine(DB00907)|Debrisoquin(DB04840)|Desipramine(DB01151)|Diethylpropion(DB00937)|Doxepin(DB01142)|Duloxetine(DB00476)|Ergotamine(DB00696)|Guanadrel Sulfate(DB00226)|Guanethidine(DB01170)|Imipramine(DB00458)|Maprotiline(DB00934)|Mazindol(DB00579)|Methylphenidate(DB00422)|Milnacipran(DB04896)|Nefazodone(DB01149)|Norepinephrine(DB00368)|Nortriptyline(DB00540)|Paroxetine(DB00715)|Phenmetrazine(DB00830)|Phentermine(DB00191)|Protriptyline(DB00344)|Reboxetine(DB00234)|Sibutramine(DB01105)|Tramadol(DB00193)|Trazodone(DB00656)|Trimipramine(DB00726)|Venlafaxine(DB00285)	TGGAATTTACGTCTTGACCCT	0.522													0	1.98E-03	0	0	0	43	7
IRF3	3661	broad.mit.edu	37	19	50165681	50165681	+	Splice_Site	SNP	C	T	T			TCGA-FE-A23A-01A-11D-A17V-08	TCGA-FE-A23A-10A-01D-A17V-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	60711e67-e8c1-470a-8e9e-1b87e0499e61	7ead3f16-6be4-4546-872e-6af784e1258c	g.chr19:50165681C>T	uc002poy.2	-	4	1620	c.601_splice	c.e4+1	p.E201_splice	IRF3_uc021uxp.1_Splice_Site_p.E55_splice|IRF3_uc021uxq.1_Splice_Site_p.E55_splice|IRF3_uc002pot.2_Splice_Site_p.D201_splice|IRF3_uc021uxr.1_Splice_Site_p.D55_splice|IRF3_uc021uxs.1_Splice_Site_p.D55_splice|IRF3_uc002pow.3_Splice_Site_p.E201_splice|IRF3_uc021uxo.1_Splice_Site_p.E166_splice|IRF3_uc002pou.3_Splice_Site_p.E201_splice|IRF3_uc010end.2_Splice_Site_p.E201_splice|IRF3_uc002poz.1_Splice_Site_p.E201_splice|BCL2L12_uc002ppa.3_5'Flank|BCL2L12_uc002ppb.3_5'Flank	NM_001197126	NP_001184055	Q14653	IRF3_HUMAN	Homo sapiens interferon regulatory factor 3 (IRF3), transcript variant 6, mRNA.	201	Involved in HERC5 binding.				MyD88-independent toll-like receptor signaling pathway|Toll signaling pathway|interferon-gamma-mediated signaling pathway|interspecies interaction between organisms|negative regulation of type I interferon production|response to virus|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway|transcription from RNA polymerase II promoter|type I interferon-mediated signaling pathway	cytosol|endosome membrane|nucleoplasm|plasma membrane	DNA binding|protein homodimerization activity|sequence-specific DNA binding transcription factor activity|transcription cofactor activity			breast(1)|large_intestine(2)|lung(4)|ovary(2)|stomach(1)	10		all_lung(116;3.24e-07)|Lung NSC(112;1.6e-06)|all_neural(266;0.0459)|Ovarian(192;0.0728)		OV - Ovarian serous cystadenocarcinoma(262;0.0011)|GBM - Glioblastoma multiforme(134;0.02)		CTGACACTCACCTTCCCCCGG	0.662													0	1.98E-03	0	0	0	16	6
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	T	T	rs121913377		TCGA-FE-A23A-01A-11D-A17V-08	TCGA-FE-A23A-10A-01D-A17V-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	60711e67-e8c1-470a-8e9e-1b87e0499e61	7ead3f16-6be4-4546-872e-6af784e1258c	g.chr7:140453136A>T	uc003vwc.4	-	14	1860	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333	NP_004324	P15056	BRAF_HUMAN	Homo sapiens v-raf murine sarcoma viral oncogene homolog B1 (BRAF), mRNA.	600	Protein kinase.		V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).		activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(41204)|p.V600K(615)|p.V600?(377)|p.V600R(99)|p.V600D(40)|p.V600_K601>E(30)|p.V600L(28)|p.V600A(24)|p.V600G(22)|p.V600M(22)|p.A598_T599insV(7)|p.T599_V600insT(7)|p.T599I(5)|p.V600Q(4)|p.T599_R603>I(4)|p.T599_V600insTT(3)|p.T599_V600insDFGLAT(2)|p.T599_V600>IAL(2)|p.V600_S605>EK(2)|p.T599T(2)|p.V600_S605>DV(2)|p.V600_S605>D(2)|p.V600_W604del(1)|p.V600V(1)|p.T599_V600insV(1)|p.V600>DLAT(1)|p.D594_T599del(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""		Cardio-facio-cutaneous syndrome		Cardiofaciocutaneous syndrome				0	6.21E-03	0	0	0	21	10
STRN	6801	broad.mit.edu	37	2	37088300	37088300	+	Silent	SNP	G	C	C			TCGA-FE-A23A-01A-11D-A17V-08	TCGA-FE-A23A-10A-01D-A17V-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	60711e67-e8c1-470a-8e9e-1b87e0499e61	7ead3f16-6be4-4546-872e-6af784e1258c	g.chr2:37088300G>C	uc002rpn.3	-	12	1653	c.1644C>G	c.(1642-1644)ccC>ccG	p.P548P	STRN_uc010ezx.3_Silent_p.P511P	NM_003162	NP_003153	O43815	STRN_HUMAN	Homo sapiens striatin, calmodulin binding protein (STRN), mRNA.	548					Wnt receptor signaling pathway|dendrite development|locomotory behavior|negative regulation of cell proliferation|tight junction assembly	cytoplasm|dendritic spine|neuronal cell body|postsynaptic density|postsynaptic membrane|tight junction	armadillo repeat domain binding|calmodulin binding|estrogen receptor binding|protein complex binding|protein phosphatase 2A binding			breast(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(5)|lung(16)|pancreas(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(2)	33		Ovarian(717;0.0129)|all_hematologic(82;0.21)				GGTCGATGTTGGGATTAGTGG	0.408													0	2.48E-04	0	0	0	35	3
OR4L1	122742	broad.mit.edu	37	14	20528322	20528322	+	Missense_Mutation	SNP	T	A	A			TCGA-FE-A23A-01A-11D-A17V-08	TCGA-FE-A23A-10A-01D-A17V-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	60711e67-e8c1-470a-8e9e-1b87e0499e61	7ead3f16-6be4-4546-872e-6af784e1258c	g.chr14:20528322T>A	uc001vwn.1	+	0	119	c.119T>A	c.(118-120)aTg>aAg	p.M40K		NM_001004717	NP_001004717	Q8NH43	OR4L1_HUMAN	Homo sapiens olfactory receptor, family 4, subfamily L, member 1 (OR4L1), mRNA.	40			M -> V (in dbSNP:rs1958716).		sensory perception of smell	integral to membrane|plasma membrane	olfactory receptor activity	p.M40I(1)		central_nervous_system(1)|endometrium(3)|large_intestine(4)|lung(16)|ovary(2)|pancreas(2)|skin(4)|upper_aerodigestive_tract(1)|urinary_tract(1)	34	all_cancers(95;0.00108)		Epithelial(56;4.65e-07)|all cancers(55;2.9e-06)	GBM - Glioblastoma multiforme(265;0.0064)		GCTACTGTGATGGGAAACATT	0.398													0	3.95E-03	0	0	0	36	12
